Neutrophil-to-Lymphocyte Ratio Is a Major Prognostic Factor in Non-small Cell Lung Carcinoma Patients Undergoing First Line Immunotherapy With PembrolizumabFrancesco Jacopo Romano, Ferdinando Riccardi, Riccardo Ronga et al.|Cancer Diagnosis & Prognosis|2022Cited by 28
In the Era of Cardiovascular–Kidney–Metabolic Syndrome in Cardio-Oncology: From Pathogenesis to Prevention and TherapyVincenzo Quagliariello, Nicola Maurea, Massimiliano Berretta et al.|Cancers|2025Cited by 25
Glucagon-like Peptide 1 Receptor Agonists in Cardio-Oncology: Pathophysiology of Cardiometabolic Outcomes in Cancer PatientsVincenzo Quagliariello, Nicola Maurea, Maria Laura Canale et al.|International Journal of Molecular Sciences|2024Cited by 18
The sGCa Vericiguat Exhibit Cardioprotective and Anti-Sarcopenic Effects through NLRP-3 Pathways: Potential Benefits for Anthracycline-Treated Cancer PatientsVincenzo Quagliariello, Nicola Maurea, Massimiliano Berretta et al.|Cancers|2024Cited by 14
Effect of sodium-glucose cotransporter 2 inhibitor dapagliflozin on ejection fraction reduction, myocardial and renal NF-κB expression and systemic pro-inflammatory biomarkers in models of short-term doxorubicin cardiotoxicity.Vincenzo Quagliariello, Nicola Maurea, Maria Laura Canale et al.|Journal of Clinical Oncology|2024Cited by 3